11.11.2009 • News

Rohnerchem Names New Head of Corporate Development

Rohnerchem is intensifying its business activities in European and U.S. markets to develop solid, long-term partnerships with customers and establish networks, strategic alliances and cooperations with partners and universities. To achieve this aim, Andres Tschupp joins Rohnerchem as of August 13 as Head of Corporate Development. He will be responsible for identifying market trends, evaluating new business ideas and segments and establishing collaborations with partners within the pharmaceutical and various speciality chemicals industries. Andres Tschupp has a long experience in Business Development at an executive level with Lonza in Switzerland and is a governing board member of an international pharmaceutical company. Rohnerchem significantly strengthens its market activities with this additional strategic function reporting directly to the CEO.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read